BioXcel Financial Statements (BTAI)

BioXcelsmart-lab.ru %   2020 2021 2022 2022 2023   LTM ?
Report date 12.03.2021 11.03.2022 16.03.2023 01.05.2023 22.03.2024   06.08.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 0.000 0.000 0.375 0.375 1.38   2.40
Operating Income, bln rub -82.3 -106.9 -159.6 -159.6 -166.3   -108.0
EBITDA, bln rub ? -82.3 -106.9 -157.5 -157.5 -166.0   -102.5
Net profit, bln rub ? -82.0 -106.6 -171.8 -171.8 -179.1   -107.8
OCF, bln rub ? -66.4 -82.2 -135.3 -135.3 -155.0   -105.3
CAPEX, bln rub ? 0.316 0.445 0.139 0.139 0.020   0.000
FCF, bln rub ? -66.7 -82.6 -135.5 -135.5 -155.0   -105.3
Dividend payout, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 82.3 106.9 160.0 160.0 166.1   104.7
Cost of production, bln rub 0.188 0.297 0.020 0.020 1.58   1.60
R&D, bln rub 58.0 52.7 91.2 91.2 82.9   48.2
Interest expenses, bln rub 0.027 0.040 8.21 8.21 13.3   14.0
Assets, bln rub 219.9 239.4 205.9 205.9 73.7   65.4
Net Assets, bln rub ? 206.7 221.7 76.8 76.8 -56.5   -74.3
Debt, bln rub 1.64 1.40 94.2 94.2 101.4   103.6
Cash, bln rub 213.1 233.0 193.7 193.7 65.2   56.3
Net debt, bln rub -211.5 -231.6 -99.6 -99.6 36.2   47.4
Ordinary share price, rub 46.2 20.3 21.5 21.5 2.95   4.00
Number of ordinary shares, mln 21.7 26.4 28.0 28.0 29.1   40.3
Market cap, bln rub 1 002 536 602 602 86   161
EV, bln rub ? 790 305 502 502 122   208
Book value, bln rub 207 222 77 77 -57   -74
EPS, rub ? -3.78 -4.04 -6.13 -6.13 -6.15   -2.68
FCF/share, rub -3.07 -3.13 -4.84 -4.84 -5.32   -2.62
BV/share, rub 9.53 8.41 2.74 2.74 -1.94   -1.85
EBITDA margin, % ? -42 012% -42 012% -12 030%   -4 264%
Net margin, % ? -45 826% -45 826% -12 975%   -4 487%
FCF yield, % ? -6.65% -15.4% -22.5% -22.5% -180.4%   -65.4%
ROE, % ? -39.7% -48.1% -223.8% -223.8% 316.9%   145.1%
ROA, % ? -37.3% -44.5% -83.5% -83.5% -242.9%   -164.8%
P/E ? -12.2 -5.03 -3.50 -3.50 -0.48   -1.49
P/FCF -15.0 -6.49 -4.44 -4.44 -0.55   -1.53
P/S ? 1 605 1 605 62.3   67.0
P/BV ? 4.85 2.42 7.84 7.84 -1.52   -2.17
EV/EBITDA ? -9.60 -2.85 -3.19 -3.19 -0.74   -2.03
Debt/EBITDA 2.57 2.17 0.63 0.63 -0.22   -0.46
R&D/CAPEX, % 18 353% 11 844% 65 640% 65 640% 414 665%  
CAPEX/Revenue, % 37.1% 37.1% 1.45%   0
BioXcel shareholders